BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33222313)

  • 21. Tracking the dissemination of a culturally targeted brochure to promote awareness of hereditary breast and ovarian cancer among Black women.
    Scherr CL; Bomboka L; Nelson A; Pal T; Vadaparampil ST
    Patient Educ Couns; 2017 May; 100(5):805-811. PubMed ID: 27866793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City.
    Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
    J Genet Couns; 2010 Jun; 19(3):255-68. PubMed ID: 20151317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
    Appel SJ; Cleiment RJ
    J Natl Black Nurses Assoc; 2015 Dec; 26(2):17-26. PubMed ID: 27045154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.
    Lynce F; Schlam I; Geng X; Peshkin BN; Friedman S; Dutil J; Nahleh Z; Campos C; Ricker C; Rodriguez P; Denduluri N; Ahn J; Isaacs C; Graves KD
    J Genet Couns; 2021 Apr; 30(2):383-393. PubMed ID: 33010199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community research collaboration to develop a promotores-based hereditary breast cancer education program for Spanish-speaking Latinas.
    Almeida R; Lopez-Macha A; Dugatkin T; Joseph G; Duron Y; Hurtado de Mendoza A; D Graves K; Fejerman L
    Health Educ Res; 2021 Jul; 36(3):319-336. PubMed ID: 34113985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
    Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
    Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entertainment-Education Narrative Versus Nonnarrative Interventions to Educate and Motivate Latinas to Engage in Mammography Screening.
    Borrayo EA; Rosales M; Gonzalez P
    Health Educ Behav; 2017 Jun; 44(3):394-402. PubMed ID: 27553361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
    Kinney AY; Gammon A; Coxworth J; Simonsen SE; Arce-Laretta M
    Genet Med; 2010 Feb; 12(2):105-15. PubMed ID: 20061960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A descriptive study of BRCA1 testing and reactions to disclosure of test results.
    Lynch HT; Lemon SJ; Durham C; Tinley ST; Connolly C; Lynch JF; Surdam J; Orinion E; Slominski-Caster S; Watson P; Lerman C; Tonin P; Lenoir G; Serova O; Narod S
    Cancer; 1997 Jun; 79(11):2219-28. PubMed ID: 9179070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
    Dron HA; Bucio D; Young JL; Tabor HK; Cho MK
    J Genet Couns; 2023 Feb; 32(1):166-181. PubMed ID: 36301246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sharing research results with Latina breast cancer survivors who participated in a community-engaged behavioral RCT study: a descriptive cross-sectional survey study.
    Bonilla J; Alhomsi A; Santoyo-Olsson J; Stewart AL; Ortiz C; Samayoa C; Torres-Nguyen A; Palomino H; Coleman V; Urias A; Gonzalez N; Cervantes SA; Duron Y; Nápoles AM
    Trials; 2022 Jan; 23(1):25. PubMed ID: 34998436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.
    Ackerman MG; Shapiro PA; Coe A; Trivedi MS; Crew KD
    Breast J; 2017 Sep; 23(5):519-524. PubMed ID: 28323373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.
    Henderson V; Madrigal JM; Kendall LC; Parekh P; Newsome J; Chukwudozie IB; Comer-Hagans L; Coffey V; Grumbach G; Spencer S; Rodgers C; Kaur R; Balay L; Maga T; Ramamonjiarivelo Z; Balthazar C; Winn R; Watson K; Odoms-Young A; Hoskins KF
    BMC Health Serv Res; 2022 Jun; 22(1):826. PubMed ID: 35752812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling.
    Garcia C; Sullivan MW; Lothamer H; Harrison KM; Chatfield L; Thomas MH; Modesitt SC
    J Obstet Gynaecol Res; 2020 Sep; 46(9):1835-1841. PubMed ID: 32656916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
    Katapodi MC; Munro ML; Pierce PF; Williams RA
    Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unselected Women's Experiences of Receiving Genetic Research Results for Hereditary Breast and Ovarian Cancer: A Qualitative Study.
    Forbes Shepherd R; Forrest LE; Tutty E; Pearce A; Devereux L; James PA; Campbell IG; Trainer A; Young MA
    Genet Test Mol Biomarkers; 2021 Dec; 25(12):741-748. PubMed ID: 34918982
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.